Answers are grounded in this paper and cite their sources.
Rosane Charlab1, Ruby Leong1, Stacy S. Shord1 and Gregory H. Reaman2 1Office of Clinical Pharmacology, Office of Translational Sciences, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, USA 2Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, USA Correspondence: Rosane.CharlabOrbach{at}fda.hhs.gov
No takes yet. Share an insight, caveat, or question.
Charlab et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: